We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+16.33%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.37B
AUM Growth
+$227M
Cap. Flow
-$5.81M
Cap. Flow %
-0.25%
Top 10 Hldgs %
19.78%
Holding
359
New
114
Increased
58
Reduced
128
Closed
21

Top Buys

Rank Stock Value
1
BRBR icon
BellRing Brands
BRBR
+$32M
2
QTS
QTS REALTY TRUST, INC.
QTS
+$18M
3
PRFT
Perficient Inc
PRFT
+$15.7M
4
AX icon
Axos Financial
AX
+$14.4M
5
ABCB icon
Ameris Bancorp
ABCB
+$13.4M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$33M
2
CADE
Cadence Bancorporation
CADE
+$29.6M
3
VG
Vonage Holdings Corporation
VG
+$15.7M
4
ARQL
Arqule Inc
ARQL
+$15.6M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 21.26%
2 Consumer Discretionary 16.72%
3 Industrials 15.68%
4 Technology 14.21%
5 Consumer Staples 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
26
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$26.2M 1.11%
481,494
+164,848
+52% +$8.16M
FSCT
27
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$25.7M 1.09%
783,527
-140,453
-15% -$4.6M
YETI icon
28
Yeti Holdings
YETI
$3.87B
$25.3M 1.07%
728,747
+97,079
+15% +$3.06M
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$25.2M 1.07%
195,940
+62,330
+47% +$6.01M
JACK icon
30
Jack in the Box
JACK
$286M
$25M 1.06%
320,933
-942
-0.3% -$78K
MTH icon
31
Meritage Homes
MTH
$4.95B
$24.9M 1.05%
816,118
-5,160
-0.6% -$177K
VIAV icon
32
Viavi Solutions
VIAV
$9.41B
$24.9M 1.05%
1,658,110
+593,547
+56% +$8.88M
NVRI icon
33
Enviri
NVRI
$644M
$24.6M 1.04%
1,067,948
+502,945
+89% +$10.5M
EVRI
34
DELISTED
Everi Holdings
EVRI
$24.3M 1.03%
1,810,932
+621,608
+52% +$7.09M
CCOI icon
35
Cogent Communications
CCOI
$549M
$23.4M 0.99%
355,432
+37,569
+12% +$2.27M
PS
36
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$23.3M 0.99%
1,356,526
+14,769
+1% +$251K
PRFT
37
DELISTED
Perficient Inc
PRFT
$23.3M 0.99%
506,693
+384,141
+313% +$15.7M
TNDM icon
38
Tandem Diabetes Care
TNDM
$1.17B
$22.2M 0.94%
372,004
-179,851
-33% -$11.1M
MODN
39
DELISTED
MODEL N, INC.
MODN
$21.5M 0.91%
611,961
-4,630
-0.8% -$141K
NSP icon
40
Insperity
NSP
$1.89B
$21.1M 0.89%
245,336
+36,180
+17% +$3.15M
RETA
41
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$20.9M 0.88%
102,109
-180,709
-64% -$33M
AIMT
42
DELISTED
Aimmune Therapeutics
AIMT
$20.4M 0.86%
609,523
-988
-0.2% -$27.6K
ADUS icon
43
Addus HomeCare
ADUS
$2.14B
$20.4M 0.86%
209,645
-1,650
-0.8% -$145K
TRHC
44
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$19.6M 0.83%
403,422
+17,522
+5% +$821K
OCFC icon
45
OceanFirst Financial
OCFC
$1.73B
$18.9M 0.8%
741,391
+30,730
+4% +$739K
QTS
46
DELISTED
QTS REALTY TRUST, INC.
QTS
$18.6M 0.79%
+342,980
New +$18M
AEO icon
47
American Eagle Outfitters
AEO
$2.85B
$18.5M 0.78%
1,255,421
-8,133
-0.6% -$124K
SAIL
48
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$18.4M 0.78%
781,695
+257,305
+49% +$5.63M
MNTV
49
DELISTED
Momentive Global Inc. Common Stock
MNTV
$18.4M 0.78%
1,029,738
-2,670
-0.3% -$46.9K
PTCT icon
50
PTC Therapeutics
PTCT
$6.52B
$18.2M 0.77%
379,788
+7,880
+2% +$335K
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Advisers held 359 positions worth $2.37B, up 11% from $2.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2019 filing shows 114 new, 58 increased, 128 reduced and 21 closed positions. Its largest new stake was BellRing Brands: 1,634,376 shares worth $34.8M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $33M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Emerald Advisers's largest Q4 2019 buy was BellRing Brands: 1,634,376 shares worth $34.8M.
  • Emerald Advisers added most to Perficient Inc in Q4 2019, an estimated $15.7M increase.
  • Emerald Advisers's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $33M.
  • Emerald Advisers fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $13.2M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.37B portfolio in Q4 2019.
  • Emerald Advisers opened 114 new positions and closed 21 in Q4 2019.
  • Emerald Advisers's portfolio value rose 11% quarter-over-quarter to $2.37B.

Based on Emerald Advisers's 13F filing for Q4 2019, filed 29 Jan 2020.